JP6469272B2 - ビアリール誘導体又はその塩からなる医薬 - Google Patents

ビアリール誘導体又はその塩からなる医薬 Download PDF

Info

Publication number
JP6469272B2
JP6469272B2 JP2018034369A JP2018034369A JP6469272B2 JP 6469272 B2 JP6469272 B2 JP 6469272B2 JP 2018034369 A JP2018034369 A JP 2018034369A JP 2018034369 A JP2018034369 A JP 2018034369A JP 6469272 B2 JP6469272 B2 JP 6469272B2
Authority
JP
Japan
Prior art keywords
group
compound
mmol
yield
pyridin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018034369A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018145180A (ja
JP2018145180A5 (enExample
Inventor
渡邉　篤
篤 渡邉
優樹 佐藤
優樹 佐藤
圭司 小倉
圭司 小倉
良之 巽
良之 巽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
Original Assignee
Kaken Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharmaceutical Co Ltd filed Critical Kaken Pharmaceutical Co Ltd
Publication of JP2018145180A publication Critical patent/JP2018145180A/ja
Publication of JP2018145180A5 publication Critical patent/JP2018145180A5/ja
Application granted granted Critical
Publication of JP6469272B2 publication Critical patent/JP6469272B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2018034369A 2017-03-01 2018-02-28 ビアリール誘導体又はその塩からなる医薬 Active JP6469272B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017038752 2017-03-01
JP2017038752 2017-03-01

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019004690A Division JP2019073537A (ja) 2017-03-01 2019-01-15 ビアリール誘導体又はその塩からなる医薬

Publications (3)

Publication Number Publication Date
JP2018145180A JP2018145180A (ja) 2018-09-20
JP2018145180A5 JP2018145180A5 (enExample) 2018-12-27
JP6469272B2 true JP6469272B2 (ja) 2019-02-13

Family

ID=63589494

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018034369A Active JP6469272B2 (ja) 2017-03-01 2018-02-28 ビアリール誘導体又はその塩からなる医薬
JP2019004690A Pending JP2019073537A (ja) 2017-03-01 2019-01-15 ビアリール誘導体又はその塩からなる医薬

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019004690A Pending JP2019073537A (ja) 2017-03-01 2019-01-15 ビアリール誘導体又はその塩からなる医薬

Country Status (1)

Country Link
JP (2) JP6469272B2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ775496A (en) * 2018-11-30 2026-01-30 Otsuka Pharma Co Ltd Heterocyclic compounds for the treatment of epilepsy
US20240262803A1 (en) * 2021-03-24 2024-08-08 Chungdu Anticancer Bioscience Ltd Compounds, compositions and methods of treating disorders
WO2023027162A1 (ja) * 2021-08-27 2023-03-02 科研製薬株式会社 ２－（４－エチルフェノキシ）－４'－メトキシ－３，３'－ビピリジンの結晶及びその製造方法
WO2023146512A1 (en) * 2022-01-25 2023-08-03 Vivace Therapeutics, Inc. Compounds and methods of use thereof
WO2023146511A1 (en) * 2022-01-25 2023-08-03 Vivace Therapeutics, Inc. Compounds and methods of use thereof
CN115304544B (zh) * 2022-08-01 2024-02-09 童航 一种5-溴-2-(甲基氨基)吡啶的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9505651D0 (en) * 1995-03-21 1995-05-10 Agrevo Uk Ltd AgrEvo UK Limited
US6096895A (en) * 1995-05-17 2000-08-01 E. I. Du Pont De Nemours And Company Heterocyclic dihydrazole compounds and their use for controlling fungal plant diseases
DE10038019A1 (de) * 2000-08-04 2002-02-14 Bayer Ag Substituierte Triazolopyrid(az)ine
AU2003274025A1 (en) * 2002-10-17 2004-05-04 Syngenta Participations Ag Pyridine derivatives useful as herbicides
WO2004052280A2 (en) * 2002-12-10 2004-06-24 Imclone Systems Incorporated Anti-angiogenic compounds and their use in cancer treatment
US20050113423A1 (en) * 2003-03-12 2005-05-26 Vangoor Frederick F. Modulators of ATP-binding cassette transporters
EP1888529A2 (en) * 2005-05-18 2008-02-20 Wyeth 3-cyanoquinoline inhibitors of tpl2 kinase and methods of making and using the same
UY32582A (es) * 2009-04-28 2010-11-30 Amgen Inc Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamífero
KR101301533B1 (ko) * 2010-02-09 2013-09-04 한미사이언스 주식회사 암세포 성장 억제 효과를 갖는 신규 피리미딘 유도체
ES2527188T3 (es) * 2011-09-26 2015-01-21 Sanofi Derivados de pirazolquinolinona, su preparación y su uso terapéutico
WO2016098793A1 (ja) * 2014-12-17 2016-06-23 塩野義製薬株式会社 環状グアニジル基を有するチアゾール誘導体

Also Published As

Publication number Publication date
JP2018145180A (ja) 2018-09-20
JP2019073537A (ja) 2019-05-16

Similar Documents

Publication Publication Date Title
JP6868650B2 (ja) ビアリール誘導体及びそれを含有する医薬
US11084831B1 (en) Benzopiperazine compositions as BET bromodomain inhibitors
TWI831011B (zh) Egfr抑制劑、其製備方法及用途
US11111229B2 (en) Tetrahydroquinoline compositions as BET bromodomain inhibitors
JP2019073537A (ja) ビアリール誘導体又はその塩からなる医薬
US20240254119A1 (en) COMPOUNDS AND COMPOSITIONS AS c-Kit KINASE INHIBITORS
US10844044B2 (en) WDR5 inhibitors and modulators
JP2020059651A (ja) ピラゾール誘導体及びそれを含有する医薬
US20240343704A1 (en) Halo-substituted amino pyridine compounds as inhibitors of the haematopoietic progenitor kinase 1 (hpk1)
CN117377666A (zh) 含有具有稠环的glp-1受体激动剂的药物组合物
HK1256486B (en) Biaryl derivative and medicine containing same

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181114

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20181114

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20181114

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20181127

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20181225

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190115

R150 Certificate of patent or registration of utility model

Ref document number: 6469272

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250